Interaction Between the Cytoplasmic Domain of ICAM-1 and Pr55Gag Leads to Acquisition of Host ICAM-1 by Human Immunodeficiency Virus Type 1

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 2004 Oct 14

PMID 15479832

Citations 14

Authors

Yannick Beausejour

Michel J Tremblay

Affiliations

Soon will be listed here.

Abstract

We have examined the molecular basis for the selective incorporation of the adhesion molecule ICAM-1 within human immunodeficiency virus type 1 (HIV-1). The process of ICAM-1 incorporation was investigated by using different ICAM-1 constructs in combination with virus capture and immunoprecipitation studies, Western blot and confocal microscopy analyses, and infectivity assays. Experiments conducted with viruses bearing a truncated version of ICAM-1 revealed that the cytoplasmic domain of ICAM-1 governs insertion of this adhesion molecule into HIV-1. Further experiments suggested that there is an association between ICAM-1 and the virus-encoded Pr55(Gag) polyprotein. This study represents the first demonstration that structural Gag polyproteins play a key role in the uptake of a host-derived cell surface by the virus entity. Taken together, our results indicate that interactions between viral and cellular proteins are responsible for the selective uptake of host ICAM-1 by HIV-1. This observation describes a new strategy by which HIV-1 can modulate its replicative cycle, considering that insertion of ICAM-1 within nascent virions has been shown to increase virus infectivity.

Citing Articles

Exposure to Secreted Bacterial Factors Promotes HIV-1 Replication in CD4 T Cells.

Znaidia M, de Souza-Angelo Y, Letoffe S, Staropoli I, Grzelak L, Ghigo J Microbiol Spectr. 2023; 11(2):e0431322.

PMID: 36853052 PMC: 10100953. DOI: 10.1128/spectrum.04313-22.

Host Molecule Incorporation into HIV Virions, Potential Influences in HIV Pathogenesis.

Munoz O, Banga R, Perreau M Viruses. 2022; 14(11).

PMID: 36423132 PMC: 9694329. DOI: 10.3390/v14112523.

Active PD-L1 incorporation within HIV virions functionally impairs T follicular helper cells.

Munoz O, Banga R, Schelling R, Procopio F, Mastrangelo A, Nortier P PLoS Pathog. 2022; 18(7):e1010673.

PMID: 35788752 PMC: 9286290. DOI: 10.1371/journal.ppat.1010673.

Innate Immune Response Against HIV-1.

Murugaiah V, Yasmin H, Pandit H, Ganguly K, Subedi R, Al-Mozaini M Adv Exp Med Biol. 2021; 1313:23-58.

PMID: 34661890 DOI: 10.1007/978-3-030-67452-6_3.

How HIV-1 Gag Manipulates Its Host Cell Proteins: A Focus on Interactors of the Nucleocapsid Domain.

Klingler J, Anton H, Real E, Zeiger M, Moog C, Mely Y Viruses. 2020; 12(8).

PMID: 32823718 PMC: 7471995. DOI: 10.3390/v12080888.

References

Gilbert C, Rollet-Labelle E, Naccache P . Preservation of the pattern of tyrosine phosphorylation in human neutrophil lysates. II. A sequential lysis protocol for the analysis of tyrosine phosphorylation-dependent signalling. J Immunol Methods. 2002; 261(1-2):85-101. DOI: 10.1016/s0022-1759(01)00553-1. View

Arthur L, Bess Jr J, Sowder 2nd R, Benveniste R, Mann D, Chermann J . Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science. 1992; 258(5090):1935-8. DOI: 10.1126/science.1470916. View

Cosson P . Direct interaction between the envelope and matrix proteins of HIV-1. EMBO J. 1996; 15(21):5783-8. PMC: 452325. View

Henriksson P, Bosch V . Inhibition of cellular glycoprotein incorporation into human immunodeficiency virus-like particles by coexpression of additional cellular interaction partner. Virology. 1998; 251(1):16-21. DOI: 10.1006/viro.1998.9403. View

Ono A, Freed E . Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc Natl Acad Sci U S A. 2001; 98(24):13925-30. PMC: 61143. DOI: 10.1073/pnas.241320298. View

Bounou S, Dumais N, Tremblay M . Attachment of human immunodeficiency virus-1 (HIV-1) particles bearing host-encoded B7-2 proteins leads to nuclear factor-kappa B- and nuclear factor of activated T cells-dependent activation of HIV-1 long terminal repeat transcription. J Biol Chem. 2000; 276(9):6359-69. DOI: 10.1074/jbc.M002198200. View

Mervis R, Ahmad N, Lillehoj E, Raum M, Salazar F, Chan H . The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors. J Virol. 1988; 62(11):3993-4002. PMC: 253827. DOI: 10.1128/JVI.62.11.3993-4002.1988. View

Ott D, Coren L, Johnson D, Kane B, Sowder 2nd R, Kim Y . Actin-binding cellular proteins inside human immunodeficiency virus type 1. Virology. 1999; 266(1):42-51. DOI: 10.1006/viro.1999.0075. View

Paquette J, Fortin J, Blanchard L, Tremblay M . Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity. J Virol. 1998; 72(11):9329-36. PMC: 110356. DOI: 10.1128/JVI.72.11.9329-9336.1998. View

10.

Liao Z, Roos J, Hildreth J . Increased infectivity of HIV type 1 particles bound to cell surface and solid-phase ICAM-1 and VCAM-1 through acquired adhesion molecules LFA-1 and VLA-4. AIDS Res Hum Retroviruses. 2000; 16(4):355-66. DOI: 10.1089/088922200309232. View

11.

Staunton D, Dustin M, Erickson H, Springer T . The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus. Cell. 1990; 61(2):243-54. DOI: 10.1016/0092-8674(90)90805-o. View

12.

Fortin J, Barbeau B, Hedman H, Lundgren E, Tremblay M . Role of the leukocyte function antigen-1 conformational state in the process of human immunodeficiency virus type 1-mediated syncytium formation and virus infection. Virology. 1999; 257(1):228-38. DOI: 10.1006/viro.1999.9687. View

13.

Sodeik B . Unchain my heart, baby let me go--the entry and intracellular transport of HIV. J Cell Biol. 2002; 159(3):393-5. PMC: 2173064. DOI: 10.1083/jcb.200210024. View

14.

Shoeman R, Kesselmier C, MOTHES E, Honer B, Traub P . Non-viral cellular substrates for human immunodeficiency virus type 1 protease. FEBS Lett. 1991; 278(2):199-203. DOI: 10.1016/0014-5793(91)80116-k. View

15.

Bounou S, Leclerc J, Tremblay M . Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4(+)-T-cell depletion in human lymphoid tissue, a major site of replication in vivo. J Virol. 2002; 76(3):1004-14. PMC: 135853. DOI: 10.1128/jvi.76.3.1004-1014.2002. View

16.

Ott D, Coren L, Kane B, Busch L, Johnson D, Sowder 2nd R . Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. J Virol. 1996; 70(11):7734-43. PMC: 190843. DOI: 10.1128/JVI.70.11.7734-7743.1996. View

17.

Murakami T, Freed E . Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail. J Virol. 2000; 74(8):3548-54. PMC: 111863. DOI: 10.1128/jvi.74.8.3548-3554.2000. View

18.

Adachi A, Gendelman H, Koenig S, Folks T, Willey R, Rabson A . Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol. 1986; 59(2):284-91. PMC: 253077. DOI: 10.1128/JVI.59.2.284-291.1986. View

19.

Scarlata S, Carter C . Role of HIV-1 Gag domains in viral assembly. Biochim Biophys Acta. 2003; 1614(1):62-72. DOI: 10.1016/s0005-2736(03)00163-9. View

20.

Cheng R, Kuhn R, Olson N, Rossmann M, Choi H, Smith T . Nucleocapsid and glycoprotein organization in an enveloped virus. Cell. 1995; 80(4):621-30. PMC: 4167723. DOI: 10.1016/0092-8674(95)90516-2. View